Semaan, Alexander
Bernard, Vincent
Kim, Dong U.
Lee, Jaewon J.
Huang, Jonathan
Kamyabi, Nabiollah
Stephens, Bret M.
Qiao, Wei
Varadhachary, Gauri R.
Katz, Matthew H.
Shen, Yu http://orcid.org/0000-0002-3899-7868
San Lucas, Francis Anthony
Gascoyne, Peter
Alvarez, Hector A.
Maitra, Anirban
Guerrero, Paola A. http://orcid.org/0000-0002-7345-1246
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SE-2616/2-1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA217789-03, U54CA096297, T32CA009599, CA221707, CA196403, CA200468)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Cancer Prevention and Research Institute of Texas (RP140106, RP170067, RP170067, RP160517)
National Research Foundation of Korea (2018R1C1B5086234)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 22 May 2020
Revised: 20 January 2021
Accepted: 4 March 2021
First Online: 30 March 2021
Ethics approval and consent to participate
: The study was performed in accordance with standard ethical guidelines approved by the institutional review board (IRB), protocol numbers PA11-0670 and PA15-0014 at MD Anderson Cancer Center, and in accordance with the Declaration of Helsinki. Patients provided their informed consent to participate in this study.
: All data generated and analysed during the current study are available from the corresponding author on reasonable request.
: A.M. receives royalties for a pancreatic cancer biomarker test from Cosmos Wisdom Biotechnology, and this financial relationship is managed and monitored by the UTMDACC Conflict of Interest Committee. A.M. is also listed as an inventor on a patent that has been licensed by Johns Hopkins University to Thrive Earlier Detection. The remaining authors declare no competing interests.
: This research was supported in part by the Cancer Prevention and Research Institute of Texas (CPRIT) (No. RP160517), NCI P50 CA221707, U01 CA196403 and U01 CA200468 to A.M. N.K. was supported by the CPRIT Research Training Program (No. RP170067). V.B. was supported by the CPRIT Research Training Program (Nos. RP140106 and RP170067) and NCI (Nos. T32CA217789-03 and U54CA096297). J.J.L. was supported by the National Institutes of Health (NIH) (No. T32CA009599). A.S. was supported by the German Research Foundation (SE-2616/2-1). D.U.K. was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1C1B5086234).